Heterologous cross-seeding mimics cross-species prion conversion in a yeast model

Namitha Vishveshwara1, Susan W Liebman

  • 1Department of Biological Sciences, Chicago, IL 60607, USA. namivish@yahoo.com

BMC Biology
|May 28, 2009
PubMed
Abstract

Insights

Yeast prions like Sup35p can cross the species barrier. A Pichia methanolica prion domain chimera, [CHI+PM], can be seeded by Saccharomyces cerevisiae [PSI+], forming new prion variants.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Prion Biology

Background:

  • Prions are infectious, aggregated proteins causing neurodegenerative diseases and heritable traits.
  • Yeast prions, like Sup35p, involve a functional C-terminal domain and a variable prion domain.
  • Prion domain chimeras exhibit a 'species barrier,' hindering cross-species transmission.

Purpose of the Study:

  • Investigate the 'species barrier' between Pichia methanolica and Saccharomyces cerevisiae prion chimeras.
  • Determine factors influencing the formation of a chimeric prion, [CHI+PM].
  • Characterize the properties and propagation of the [CHI+PM] prion.

Main Methods:

  • Constructed a chimera with the P. methanolica prion domain and S. cerevisiae C-terminal domain.
  • Assessed the influence of existing yeast prions ([PSI+], [PIN+]) and aggregates on [CHI+PM] formation.
  • Analyzed [CHI+PM] characteristics, including aggregation, transmission, and structural variants.

Main Results:

  • Existing Q/N-rich yeast prions ([PSI+] or [PIN+]) enhanced [CHI+PM] formation.
  • Non-Q/N-rich prions or Q-rich aggregates did not promote [CHI+PM] formation.
  • [CHI+PM] exhibited prion-like features: aggregation, cytoplasmic transmission, and distinct structural variants.

Conclusions:

  • The P. methanolica prion domain chimera ([CHI+PM]) can be cross-seeded by S. cerevisiae [PSI+], mimicking crossing the species barrier.
  • Crossing the barrier appears to involve de novo formation of the foreign chimeric prion.
  • The species barrier is overcome via heterologous seeding, using existing prions as inefficient templates.